Dynamic Technology Lab Private Ltd Makes New Investment in Masimo Corporation $MASI

Dynamic Technology Lab Private Ltd purchased a new position in shares of Masimo Corporation (NASDAQ:MASI) in the fourth quarter, Holdings Channel.com reports. The firm purchased 9,480 shares of the medical equipment provider’s stock, valued at approximately $1,233,000.

Several other institutional investors and hedge funds have also made changes to their positions in MASI. Viking Global Investors LP purchased a new stake in shares of Masimo in the 2nd quarter valued at about $129,096,000. Squarepoint Ops LLC increased its position in Masimo by 738.8% during the 3rd quarter. Squarepoint Ops LLC now owns 620,932 shares of the medical equipment provider’s stock worth $91,619,000 after purchasing an additional 546,905 shares during the period. UBS Group AG increased its position in Masimo by 252.9% during the 4th quarter. UBS Group AG now owns 599,274 shares of the medical equipment provider’s stock worth $77,942,000 after purchasing an additional 429,474 shares during the period. Norges Bank acquired a new position in Masimo during the 4th quarter worth approximately $49,087,000. Finally, Alyeska Investment Group L.P. increased its position in Masimo by 21.7% during the 3rd quarter. Alyeska Investment Group L.P. now owns 1,381,085 shares of the medical equipment provider’s stock worth $203,779,000 after purchasing an additional 246,595 shares during the period. 85.96% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

MASI has been the topic of several recent analyst reports. Weiss Ratings upgraded Masimo from a “sell (d-)” rating to a “hold (c-)” rating in a research report on Wednesday, May 6th. BTIG Research cut Masimo from a “buy” rating to a “neutral” rating in a report on Wednesday, February 18th. Wells Fargo & Company upgraded Masimo to a “hold” rating in a report on Wednesday, March 18th. Stifel Nicolaus set a $180.00 price target on Masimo in a report on Tuesday, February 17th. Finally, Wolfe Research cut Masimo from a “strong-buy” rating to a “hold” rating in a report on Thursday, February 19th. Nine research analysts have rated the stock with a Hold rating, According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $180.40.

Masimo Stock Performance

Shares of Masimo stock opened at $179.95 on Friday. Masimo Corporation has a fifty-two week low of $125.94 and a fifty-two week high of $179.99. The firm has a market cap of $9.42 billion, a PE ratio of -17.07, a P/E/G ratio of 1.82 and a beta of 1.11. The business’s fifty day moving average is $178.70 and its two-hundred day moving average is $160.55. The company has a quick ratio of 1.45, a current ratio of 2.68 and a debt-to-equity ratio of 0.56.

About Masimo

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.